Aadi Bioscience (FRA:3350) Total Inventories : €5.46 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Aadi Bioscience Total Inventories?

Aadi Bioscience's total inventories for the quarter that ended in Mar. 2024 was €5.46 Mil. Aadi Bioscience's average total inventories from the quarter that ended in Dec. 2023 to the quarter that ended in Mar. 2024 was €5.68 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Aadi Bioscience's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was €2.78.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Aadi Bioscience's Days Inventory for the three months ended in Mar. 2024 was 863.45.

Inventory Turnover measures how fast the company turns over its inventory within a year. Aadi Bioscience's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.11.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aadi Bioscience's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 1.15.

Aadi Bioscience Total Inventories Historical Data

The historical data trend for Aadi Bioscience's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aadi Bioscience Total Inventories Chart

Aadi Bioscience Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Total Inventories

1.76

5.89

Aadi Bioscience Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Inventories	Get a 7-Day Free Trial										3.55	3.19	3.39	5.89	5.46

Aadi Bioscience Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Aadi Bioscience (FRA:3350) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Aadi Bioscience's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is

	Net-Net Working Capital Per Share (Q: Mar. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(81.209	+	0.75 * 4.538	+	0.5 * 5.461	-	18.964
-	0	-	0)	/	24.5542
=	2.78

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aadi Bioscience's Days Inventory for the three months ended in Mar. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2024 )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
	=	5.6775	/	0.6	*	365 / 4
	=	863.45

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aadi Bioscience's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Mar. 2024 )	/	Average Total Inventories (Q: Mar. 2024 )
	=	0.6	/	5.6775
	=	0.11

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aadi Bioscience's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	5.6775	/	4.925
	=	1.15

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Aadi Bioscience Total Inventories Related Terms

Thank you for viewing the detailed overview of Aadi Bioscience's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Aadi Bioscience (FRA:3350) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aadi Bioscience Inc (FRA:3350) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

AADI:USA 3350:Germany

Address

17383 Sunset Boulevard, Suite A250, Pacific Palisades, CA, USA, 90272

Website

https://www.aadibio.com

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

Aadi Bioscience (FRA:3350) Headlines

No Headlines